Cigna earnings beat by $0.04, revenue topped estimates
IO Biotech , Inc. (NASDAQ:IOBT) announced that it has regained compliance with the Nasdaq Global Select Market’s minimum bid price requirement. The company received notification from Nasdaq’s Listing Qualifications Staff on June 3, 2025, confirming that its common stock has maintained a closing bid price of $1.00 or higher for at least ten consecutive business days. This achievement resolves a previous compliance issue reported on December 26, 2024, when IO Biotech’s stock price fell below the $1.00 threshold for 30 consecutive trading days, violating Nasdaq Listing Rule 5450(a)(1).
IO Biotech, a Delaware-incorporated company specializing in pharmaceutical preparations, is headquartered in Copenhagen, Denmark. The company’s common stock is traded on the Nasdaq Stock Market under the ticker symbol IOBT.
This information is based on a press release statement from the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.